Fraxel laser devices have long been used in cosmetic treatments for aging skin. Now, the re:store Dual system includes a new wavelength of laser energy that is designed to rid the skin of actinic keratosis (skin lesions that have a tendency to become cancerous). The FDA has given premarket clearance to the 1927 nanometer laser wavelength for use in treating this skin condition.

Laser Has Both Health and Aesthetic Applications

Like all Fraxel lasers, this unit is intended mainly for cosmetic use such as fading age spots and reducing other signs of sun-related aging. However, it is possible that some health insurance companies will cover the cost of the re:store procedure when deemed medically necessary for removing precancerous lesions on the face and body. Patients could experience smoother skin texture and evenness of coloration as a desirable side effect of their medical treatment. This may make it a popular choice for patients with fine lines and dark patches on their skin.

Dermatologists who are testing the thulium laser device hope that it will provide superior results to traditional C0₂ fractional resurfacing technology. In particular, the 1927 nm wavelength may cause less discomfort during treatment – allowing larger areas of skin to be covered in a single session. The Dual system also features other design improvements to increase the speed of treatment and make cooling more effective.

Study Shows Good Results for Fraxel

In a six month trial involving 21 patients with actinic keratosis on their face, chest, arms, or hands, the average reduction of lesions using the Fraxel 1927 nm laser was over 80%. This was after only 2-4 sessions a few weeks apart. Recovery time was short and there were no complications reported in this study. The laser performed as well as most other commonly used methods for removing lesions. The main benefit compared to other therapies was the improvement in aesthetic appearance after treatment.

Other Uses for This Laser

Solta Medical, the developer of the Fraxel laser device markets this technology for correcting sun damage, acne scars, wrinkles around the eyes, surgical scars, and melasma (dark pigment on the face that develops during pregnancy). It is a non-ablative laser which targets the upper and mid layers of the skin. Solta recommends the product for all skin types and most areas of the face and body. However, the determination of whether laser treatment is appropriate is one that can only be made in consultation with a dermatologist based on an individual’s actual skin condition and medical history.